Arrow Financial’s Exelixis EXEL Stock Holding History

Arrow Financial’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-510	Closed	-$11K	–	342
2022 Q2	$11K	Hold	510	–	–	﹤0.01%	286
2022 Q1	$12K	Hold	510	–	–	﹤0.01%	288
2021 Q4	$9K	Hold	510	–	–	﹤0.01%	291
2021 Q3	$11K	Hold	510	–	–	﹤0.01%	284
2021 Q2	$9K	Hold	510	–	–	﹤0.01%	289
2021 Q1	$12K	Hold	510	–	–	﹤0.01%	279
2020 Q4	$10K	Hold	510	–	–	﹤0.01%	272
2020 Q3	$12K	Hold	510	–	–	﹤0.01%	260
2020 Q2	$12K	Buy	+510	New	+$11.8K	﹤0.01%	267

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrow Financial's EXEL Position: Q3 2022 in Review

Arrow Financial sold out of Exelixis (EXEL) in Q3 2022, closing a stake of 510 shares — an estimated $11K sold.

Arrow Financial first reported a position in EXEL in Q2 2020 and held it in 9 quarters. The position peaked at $12K in Q1 2022. 400 funds tracked by Wall St. Rank hold EXEL as of Q3 2022.

Arrow Financial reported no remaining Exelixis position as of Q3 2022 after selling out during the quarter.
Arrow Financial sold 510 Exelixis shares in Q3 2022, an estimated $11K.
Arrow Financial first reported a position in Exelixis in Q2 2020 and held it in 9 quarters.
Arrow Financial's Exelixis position peaked at $12K in Q1 2022.
400 funds tracked by Wall St. Rank held Exelixis as of Q3 2022.

Based on Arrow Financial's 13F filing for Q3 2022, filed 7 Nov 2022.